Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy

Journal of the American College of Cardiology

Volumn 37, Issue 2, 2001, Pages 412-417

  Ohtsuka, Tomoaki ^a   Hamada, Mareomi ^a   Hiasa, Go ^a   Sasaki, Osamu ^a   Suzuki, Makoto ^a   Hara, Yuji ^a   Shigematsu, Yuji ^a   Hiwada, Kunio ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CYTOKINE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INTERLEUKIN 10; METOPROLOL; TUMOR NECROSIS FACTOR ALPHA;

ADRENALIN BLOOD LEVEL; ADULT; AGED; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; FEMALE; HEART DILATATION; HEART LEFT VENTRICLE SIZE; HUMAN; IMMUNOREGULATION; MALE; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BISOPROLOL; CARDIOMYOPATHY, DILATED; CYTOKINES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; MALE; METOPROLOL; MIDDLE AGED; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0035133351     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)01121-9     Document Type: Article

References (33)

1. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy
2. Effect of beta-blockade on mortality in patients with heart failure: A meta-analysis of randomized clinical trials
3. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
4. Beta-blockade in heart failure: A comparison of carvedilol with metoprolol
5. Effect of beta-blocker on left ventricular function and natriuretic peptides in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitor
6. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
7. Increased circulating cytokines in patients with myocarditis and cardiomyopathy
8. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
9. Mechanisms of pulmonary edema-induced tumor necrosis factor-alpha
10. Expression and functional significance of tumor necrosis factor receptors in human myocardium
11. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha
12. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats
13. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
14. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart
15. A tumor necrosis factor binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity
16. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes
17. Anti-inflammatory cytokine profile in human heart failure: Behavior of interleukin-10 in association with tumor necrosis factor-alpha
18. Blood pressure response to the Valsalva maneuver in pheochromocytoma and pseudopheochromocytoma
19. Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: Its relation to endothelin-1, natriuretic peptides and noradrenaline
20. Inability to produce IL-6 is a functional feature of human germinal center B lymphocytes
21. Presence of Epstein-Barr virus viral interleukin-10 in the serum of patients with non-human immunodeficiency virus-related diffuse large-cell non-Hodgkin's lymphomas
22. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
23. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure: Relation to nitric oxide-dependent vasodilation in the forearm circulation
24. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure
25. Role of cytokines in the mechanism of action of amlodipine: The PRAISE heart failure trial
26. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: Implications for clinical trials
27. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure
28. Beta-adrenergic blockade in developing heart failure: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling
29. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure
30. Safety and efficacy of a soluble p75 tumor necrosis factor receptor (Enbrel, etanarcept) in patients with advanced heart failure
31. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
32. IL-10 inhibits cytokine production by activated macrophages
33. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia